EGT-022

N/A

Report date: 2024/10/16 09:38:11

Base Information

Drug NameEGT-022
Drug Alias NameEG-MirotinEG-DecorinEGT-022EG-22HU-005
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIntegrin alpha-IIb/beta-3 stimulantsAngiogenesis inducers
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsPressure Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEyegene Inc
China Registration ClassN/A

Develop Information

Active CompaniesEyegene IncKukje Pharma Co LtdTianjin International Biomedicine Joint Research Institute
Inactive CompaniesN/A
Active IndicationsPressure Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A